Literature DB >> 20671291

Cardiac oxytocin receptor blockade stimulates adverse cardiac remodeling in ovariectomized spontaneously hypertensive rats.

Marek Jankowski1, Donghao Wang, Bogdan Danalache, Marius Gangal, Jolanta Gutkowska.   

Abstract

An increasing amount of evidence demonstrates the beneficial role of oxytocin (OT) in the cardiovascular system. Similar actions are attributed to genistein, an isoflavonic phytoestrogen. The treatment with genistein activates the OT system in the aorta of ovariectomized (OVX) Sprague-Dawley (SD) rats. The objective of this study was to determine the effects of low doses of genistein on the OT-induced effects in rat hypertension. The hypothesis tested was that treatment of OVX spontaneously hypertensive rats (SHRs) with genistein improves heart structure and heart work through a mechanism involving the specific OT receptor (OTR). OVX SHRs or SD rats were treated with genistein (in microg/g body wt sc, 10 days) in the presence or absence of an OT antagonist (OTA) [d(CH(2))(5), Tyr(Me)(2), Orn(8)]-vasotocin or a nonspecific estrogen receptor antagonist (ICI-182780). Vehicle-treated OVX rats served as controls. RT-PCR and Western blot analysis demonstrated that left ventricular (LV) OTR, downregulated by ovariectomy, increased in response to genistein. In SHRs or SD rats, this effect was blocked by OTA or ICI-182780 administration. The OTR was mainly localized in microvessels expressing the CD31 marker and colocalized with endothelial nitric oxide synthase. In SHRs, the genistein-stimulated OTR increases were associated with improved fractional shortening, decreased blood pressure (12 mmHg), decreased heart weight-to-body weight ratio, decreased fibrosis, and lowered brain natriuretic peptide in the LV. The prominent finding of the study is the detrimental effect of OTA treatment on the LV of SHRs. OTA treatment of OVX SHRs resulted in a dramatic worsening of ejection fractions and an augmented fibrosis. In conclusion, these results demonstrate that cardiac OTRs are involved in the regulation of cardiac function of OVX SHRs. The decreases of OTRs may contribute to cardiac pathology following menopause.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20671291     DOI: 10.1152/ajpheart.00487.2009

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  10 in total

Review 1.  Monocyte and macrophage heterogeneity in the heart.

Authors:  Matthias Nahrendorf; Filip K Swirski
Journal:  Circ Res       Date:  2013-06-07       Impact factor: 17.367

Review 2.  Oxytocin and Related Peptide Hormones: Candidate Anti-Inflammatory Therapy in Early Stages of Sepsis.

Authors:  Syed Faizan Mehdi; Suma Pusapati; Raja Ram Khenhrani; Muhammad Saad Farooqi; Sobia Sarwar; Ahmad Alnasarat; Nimisha Mathur; Christine Noel Metz; Derek LeRoith; Kevin J Tracey; Huan Yang; Michael J Brownstein; Jesse Roth
Journal:  Front Immunol       Date:  2022-04-29       Impact factor: 8.786

Review 3.  Protective cardiovascular and renal actions of vitamin D and estrogen.

Authors:  Pandu R Gangula; Yuan-Lin Dong; Ayman Al-Hendy; Gloria Richard-Davis; Valerie Montgomery-Rice; Georges Haddad; Rihcard Millis; Susanne B Nicholas; Diane Moseberry
Journal:  Front Biosci (Schol Ed)       Date:  2013-01-01

4.  Colloidal aggregation causes inhibition of G protein-coupled receptors.

Authors:  Maria F Sassano; Allison K Doak; Bryan L Roth; Brian K Shoichet
Journal:  J Med Chem       Date:  2013-03-12       Impact factor: 7.446

Review 5.  The role of oxytocin in cardiovascular regulation.

Authors:  J Gutkowska; M Jankowski; J Antunes-Rodrigues
Journal:  Braz J Med Biol Res       Date:  2014-03-18       Impact factor: 2.590

6.  Sex-Dependent Effects of Dietary Genistein on Echocardiographic Profile and Cardiac GLUT4 Signaling in Mice.

Authors:  Lana Leung; Joshua B Martin; Todd Lawmaster; Kathryn Arthur; Tom L Broderick; Layla Al-Nakkash
Journal:  Evid Based Complement Alternat Med       Date:  2016-07-04       Impact factor: 2.629

Review 7.  Therapeutic Potential of Oxytocin in Atherosclerotic Cardiovascular Disease: Mechanisms and Signaling Pathways.

Authors:  Ping Wang; Stephani C Wang; Haipeng Yang; Chunmei Lv; Shuwei Jia; Xiaoyu Liu; Xiaoran Wang; Dexin Meng; Danian Qin; Hui Zhu; Yu-Feng Wang
Journal:  Front Neurosci       Date:  2019-05-21       Impact factor: 4.677

Review 8.  Cardiovascular protective properties of oxytocin against COVID-19.

Authors:  Stephani C Wang; Yu-Feng Wang
Journal:  Life Sci       Date:  2021-01-26       Impact factor: 6.780

Review 9.  Complementary Role of Oxytocin and Vasopressin in Cardiovascular Regulation.

Authors:  Ewa Szczepanska-Sadowska; Agnieszka Wsol; Agnieszka Cudnoch-Jedrzejewska; Tymoteusz Żera
Journal:  Int J Mol Sci       Date:  2021-10-24       Impact factor: 5.923

10.  Maternal Separation Induces Long-Term Alterations in the Cardiac Oxytocin Receptor and Cystathionine γ-Lyase Expression in Mice.

Authors:  Daniela C Wigger; Nicole Gröger; Alexandra Lesse; Sabrina Krause; Tamara Merz; Harald Gündel; Katharina Braun; Oscar McCook; Peter Radermacher; Jörg Bock; Christiane Waller
Journal:  Oxid Med Cell Longev       Date:  2020-01-24       Impact factor: 6.543

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.